Your gift is 100% tax deductible
October 9 is DAF Day! Use your Donor Advised Fund to help save lives today. Give Now.
Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Every donation counts.
Your gift helps fund crucial, lifesaving research and support for
those facing breast cancer.
The amount must be greater than or equal to $5
Your gift is 100% tax deductible
Chemotherapy (chemo) is the use of drugs to treat cancer. Chemo can be given systemically through the vein or locally to the eye to help treat retinoblastoma.
Chemo drugs can be injected into a vein (IV) or given by mouth. These drugs enter the bloodstream and reach throughout the body. This is known as systemic chemotherapy.
Systemic chemo is given in cycles, with each treatment followed by a rest period to give the body time to recover. Each chemo cycle typically lasts for a few weeks, and the total length of treatment is often several months.
Some of the chemo drugs used to treat retinoblastoma include:
Most often, 2 or 3 drugs are given at the same time. A standard combination is carboplatin, vincristine, and etoposide. Although, for very small tumors, using only carboplatin and vincristine may be enough. Other drugs might be used if these are not effective. Other combinations are being tested in clinical trials.
Local administration of chemo can be given directly into the eye (intravitreal) or into the artery supplying the eye (intraarterial). Giving chemo this way, compared to systemic chemo, may reduce side effects.
In this technique, a very thin catheter (a long hollow and flexible tube) is inserted into a large artery on the inner thigh and slowly threaded through the blood vessels all the way up into the ophthalmic artery, the vessel that carries blood to the eye. This is done with the child asleep under general anesthesia. The chemo is then given into the artery. Drugs that may be given intraarterially include:
This process may then be repeated every few weeks, depending on how much the tumor shrinks.
Because chemo is put directly into the artery feeding the eye, doctors can use much smaller doses of chemo drugs (less than 10% of the doses used for systemic chemo). Therefore, there are fewer side effects from the chemo.
Results so far with this technique in eyes with advanced tumors have been good. In many cases it has allowed doctors to save an eye that otherwise would have needed to be removed.
In this approach, a tiny needle is used to inject a chemo drug (typically melphalan or topotecan) directly into the vitreous humor, the jelly-like substance inside the eye. Chemo drugs given by this way include:
This is sometimes used with other treatments to treat tumors that are widespread within the eye that have not responded to other treatments.
Chemotherapy (chemo) may be used to treat retinoblastoma in different situations:
Chemo drugs affect cells that grow fast. While cancer cells grow fast, other healthy cells in the body do too, for example blood-forming cells, hair cells, and cells that make up the lining of our gut. Damage caused by these drugs on fast-growing healthy cells results in side effects. The side effects of chemo depend on the types and doses of drugs used, and how long they are given.
Systemic chemo is more likely to affect other healthy cells through the body than chemo that is given locally. Possible short-term side effects include:
Chemo can damage the bone marrow, where new blood cells are made. This can lead to low blood cell counts, which can result in:
Most of these side effects tend to go away after treatment is finished. There are often ways to lessen these side effects. For example, drugs can be given to help prevent or reduce nausea and vomiting. Be sure to ask your child’s doctor or nurse about medicines to help reduce side effects and let them know if your child has side effects so they can be managed.
Chemotherapy can also have some longer-term side effects. For example, some drugs (such as etoposide) can increase the risk of later developing another type of cancer (such as leukemia). While this is a serious risk, it is not common, and the small increase in risk must be weighed against the importance of chemotherapy in treating retinoblastoma. For more on the possible long-term effects of treatment, see After Treatment for Retinoblastoma.
Intraarterial chemo: Much lower doses of chemo are used in this approach, so the side effects tend to be limited to the eye area. Possible side effects include:
While doctors hope that giving chemo directly to the eye area at lower doses will lead to better long-term health in survivors, it will take many years to know what side effects occur from these treatments. Treatment might affect the small blood vessels in and around the eye, which could affect vision as the child gets older. This approach also exposes the child to some radiation, because x-rays are used to help guide the catheter into place. It is not yet clear whether this affects a child’s risk of developing cataracts or cancer later in life.
Intravitreal chemo: As with intraarterial chemo, the side effects from this newer technique seem to be limited to the eye and nearby areas. Each treatment might damage the retina slightly, which might affect vision as the child gets older.
In the past, there was concern that placing a needle into the eye to give the chemo might open a small hole that could allow tumor cells to spread outside of the eye. However, studies have found that this risk is very low, and doctors now use techniques that lower this risk even further.
Along with the effects listed above, certain chemo drugs can cause specific side effects. For example:
Cisplatin and carboplatin can affect the kidneys. Giving plenty of fluids can help reduce this risk. These drugs can also cause hearing loss in young children, especially in babies younger than 6 months. Your child’s doctor may order hearing tests (audiograms) during or after treatment.
Vincristine can cause nerve damage (neuropathy). Some children may feel tingling, numbness, weakness or pain, particularly in the hands and feet. Most of the time symptoms get better when treatment ends, but they may not go away completely.
Doxorubicin can damage the heart. Doctors try to reduce this risk as much as possible by limiting the doses of doxorubicin, checking the heart with an echocardiogram (an ultrasound of the heart), and giving medicine to protect the heart (such as dexrazoxane) during treatment. Doxorubicin can also cause skin damage if it leaks out of the vein while it is being given.
Cyclophosphamide can damage the bladder, which can cause blood in the urine. The risk of this can be lowered by giving the drug with plenty of fluids and with a drug called mesna, which helps protect the bladder. This drug can also damage the ovaries or testicles, which could affect fertility (the ability to have children).
For more general information about how chemotherapy is used to treat cancer, see Chemotherapy.
To learn about some of the side effects listed here and how to manage them, see Managing Cancer-related Side Effects.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Leahey AM, Gombos DS, Chevez-Barrios P. Chapter 32: Retinoblastoma. In: Blaney SM, Adamson PC, Helman LJ, eds. Pizzo and Poplack’s Pediatric Oncology. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2021.
National Cancer Institute. Retinoblastoma Treatment (PDQ®). 2025. Accessed at www.cancer.gov/types/retinoblastoma/hp/retinoblastoma-treatment-pdq on July 2, 2025.
Rodriguez-Galindo C, Orbach DB, VanderVeen D. Retinoblastoma. Pediatr Clin North Am. 2015;62(1):201-223.
Smith SJ, Smith BD. Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: A systematic review. Br J Ophthalmol. 2013;97(10):1231-1236.
Smith SJ, Smith BD, Mohney BG. Ocular side effects following intravitreal injection therapy for retinoblastoma: A systematic review. Br J Ophthalmol. 2014; 98(3): 292-297.
Last Revised: September 11, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.